CB Financial Services, Inc. (PA) (CBFV) Dividend History

CB Financial Services, Inc. (CBFV) is a regional bank holding company based in Pennsylvania. It offers a range of banking services, including deposit accounts, commercial and retail lending, and wealth management. The company primarily serves individuals, small businesses, and commercial clients within its community-focused regional markets.

100 North Market Street, Carmichaels, PA, 15320
Phone: 724-966-5041
Dividend Yield: 3.21%
Dividend Frequency: Quarterly

Dividend History

Pay Date Amount Ex Dividend Date Record Date
August 29, 2025 $0.26 08/15/2025 08/15/2025
May 30, 2025 $0.25 05/16/2025 05/16/2025
February 28, 2025 $0.25 02/14/2025 02/14/2025
November 29, 2024 $0.25 11/15/2024 11/15/2024
August 30, 2024 $0.25 08/15/2024 08/15/2024
Show more

Dividends Summary

  • CB Financial Services, Inc. (PA) has issued 72 dividend payments over the past 22 years
  • The most recent dividend was paid 55 days ago, on May 30, 2025
  • The first recorded dividend was paid on December 19, 2003
  • The highest dividend payout was $0.42 per share
  • The average dividend over this 22 year span is $0.25 per share
  • CB Financial Services, Inc. (PA) has increased its dividend payments by 36.84% since 2003

Company News

  • CB Financial Services (CBFV) delivered earnings and revenue surprises of 16.98% and 11.63%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

    Zacks Investment Research
    Featured Companies: MBCN
  • Upgrades UBS upgraded the previous rating for Aemetis Inc (NASDAQ:AMTX) from Neutral to Buy. For the second quarter, Aemetis had an EPS of $0.68, compared to year-ago quarter EPS of $0.01. The stock has a 52-week-high of $10.74 and a 52-week-low of $1.16. At the end of the last trading period, Aemetis closed at $6.16. According to Exane BNP Paribas, the prior rating for Revance Therapeutics Inc (NASDAQ:RVNC) was changed from Underperform to Neutral. In the second quarter, Revance Therapeutics showed an EPS of $0.80, compared to $0.88 from the year-ago quarter. The current stock performance of Revance Therapeutics shows a 52-week-high of $37.98 and a 52-week-low of $17.97. Moreover, at the end of the last trading period, the closing price was at $18.80. For Inter & Co Inc (NASDAQ:INTR), Citigroup upgraded the previous rating of Neutral to Buy. For the second quarter, Inter & Co had an EPS of $0.02, compared to year-ago quarter EPS of $0.01. At the moment, the stock has a 52-week-high of $4.63 and a 52-week-low of $1.37. Inter & Co closed at $3.94 at the end of the last trading period. Evercore ISI Group upgraded the previous rating for Magnite Inc (NASDAQ:MGNI) from In-Line to Outperform. For the second quarter, Magnite had an EPS of $0.09, compared to year-ago quarter EPS of $0.14. At the moment, the stock has a 52-week-high of $15.73 and a 52-week-low of $5.58. Magnite closed at $8.52 at the end of the last trading period. For National CineMedia Inc (NASDAQ:NCMI), Benchmark upgraded the previous rating of Hold to Speculative Buy. National CineMedia earned $0.08 in the fourth quarter, compared to $0.05 in the year-ago quarter. The current stock performance of National CineMedia shows a 52-week-high of $18.20 and a 52-week-low of $1.01. Moreover, at the end of the last trading period, the closing price was at $3.55. JP Morgan upgraded the previous rating for Gulfport Energy Corp (NYSE:GPOR) from Neutral to Overweight. In the second quarter, Gulfport Energy showed an EPS of $2.66, compared to $5.09 from the year-ago quarter. The current stock performance of Gulfport Energy shows a 52-week-high of $114.88 and a 52-week-low of $60.15. Moreover, at the end of the last trading period, the closing price was at $112.23. JP Morgan upgraded the previous rating for SM Energy Co (NYSE:SM) from Neutral to Overweight. For the second quarter, SM Energy had an EPS of $1.28, compared to year-ago quarter EPS of $2.19. The current stock performance of SM Energy shows a 52-week-high of $48.54 and a 52-week-low of $24.66. Moreover, at the end of the last trading period, the closing price was at $39.01. According to JP Morgan, the prior rating for Pioneer Natural Resources Co (NYSE:PXD) was changed from Neutral to Overweight. In the second quarter, Pioneer Natural Resources showed an EPS of $4.49, compared to $9.36 from the year-ago quarter. At the moment, the stock has a 52-week-high of $274.42 and a 52-week-low of $177.26. Pioneer Natural Resources closed at $233.72 at the end of the last trading period. BMO Capital upgraded the previous rating for CareTrust REIT Inc (NYSE:CTRE) from Market Perform to Outperform. In the second quarter, CareTrust REIT showed an EPS of $0.35, compared to $0.37 from the year-ago quarter. The current stock performance of CareTrust REIT shows a 52-week-high of $22.09 and a 52-week-low of $16.22. Moreover, at the end of the last trading period, the closing price was at $19.89. According to Citigroup, the prior rating for Callon Petroleum Co (NYSE:CPE) was changed from Neutral to Buy. In the second quarter, Callon Petroleum showed an EPS of $1.99, compared to $3.68 from the year-ago quarter. At the moment, the stock has a 52-week-high of $50.10 and a 52-week-low of $28.91. Callon Petroleum closed at $35.59 at the end of the last trading period. According to Mizuho, the prior rating for Permian Resources Corp (NYSE:PR) was changed from Neutral to Buy. At the moment, the stock has a 52-week-high of $12.62 and a 52-week-low of $6.12. Permian Resources closed at $12.16 at the end of the last trading period. According to Mizuho, the prior rating for Matador Resources Co (NYSE:MTDR) was changed from Neutral to Buy. In the second quarter, Matador Resources showed an EPS of $1.42, compared to $3.47 from the year-ago quarter. The current stock performance of Matador Resources shows a 52-week-high of $73.76 and a 52-week-low of $42.04. Moreover, at the end of the last trading period, the ...Full story available on Benzinga.com

    Benzinga
Page data last updated 07/23/2025 17:04:57 UTC Dividend yield is calculated using only dividends that have already been paid. Future or declared dividends are not included